CCDC75 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.717780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.289600E-01
Normal-vs-Stage2
1.874830E-01
Normal-vs-Stage3
3.034400E-01
Normal-vs-Stage4
9.376200E-01
Stage1-vs-Stage2
4.474000E-01
Stage1-vs-Stage3
1.832430E-01
Stage1-vs-Stage4
5.589400E-01
Stage2-vs-Stage3
2.871000E-01
Stage2-vs-Stage4
1.625560E-01
Stage3-vs-Stage4
1.704020E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.729640E-01
Normal-vs-AfricanAmerican
8.396800E-01
Normal-vs-Asian
2.939200E-01
Caucasian-vs-AfricanAmerican
1.703230E-01
Caucasian-vs-Asian
5.040600E-03
AfricanAmerican-vs-Asian
1.139630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.593400E-01
Normal-vs-Female
2.125000E-01
Male-vs-Female
9.962000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.537600E-01
Normal-vs-Age(41-60Yrs)
3.187400E-01
Normal-vs-Age(61-80Yrs)
1.507370E-01
Normal-vs-Age(81-100Yrs)
1.268440E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.034800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.699400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.162200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.026600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.771400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.469200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.850000E-01
Normal-vs-Daily Drinker
3.322200E-01
Normal-vs-Weekly Drinker
3.089200E-01
Normal-vs-Occasional Drinker
1.955840E-01
Normal-vs-Social Drinker
5.709000E-01
Non Drinker-vs-Daily Drinker
3.873600E-01
Non Drinker-vs-Weekly Drinker
5.809600E-01
Non Drinker-vs-Occasional Drinker
1.600820E-01
Non Drinker-vs-Social Drinker
2.212200E-01
Daily Drinker-vs-Weekly Drinker
3.273800E-01
Daily Drinker-vs-Occasional Drinker
4.814200E-02
Daily Drinker-vs-Social Drinker
1.168170E-01
Weekly Drinker-vs-Occasional Drinker
7.694400E-01
Weekly Drinker-vs-Social Drinker
5.404800E-01
Occasional Drinker-vs-Social Drinker
6.267400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.962400E-01
Normal-vs-Grade 2
3.798800E-01
Normal-vs-Grade 3
2.917800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.702400E-01
Grade 1-vs-Grade 3
2.983200E-01
Grade 1-vs-Grade 4
4.962400E-01
Grade 2-vs-Grade 3
8.693800E-01
Grade 2-vs-Grade 4
3.798800E-01
Grade 3-vs-Grade 4
2.917800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.069600E-01
Normal-vs-NonDiabetic
6.339600E-02
Diabetic-vs-NonDiabetic
4.788200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.476200E-01
Normal-vs-NoPancreatitis
1.233770E-01
Pancreatitis-vs-NoPancreatitis
7.191700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.236000E-01
Normal-vs-N1
1.831350E-01
N0-vs-N1
8.162600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.312810E-01
Normal-vs-TP53-NonMutant
3.837600E-01
TP53-Mutant-vs-TP53-NonMutant
3.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
